Scott Blanchette

Technology and Product Director at formerly Arsenal Capital Partners

Speaker

Scott Blanchette served as a senior technology and product advisor to Arsenal Capital Partners twelve health and life sciences companies and serves as Chairman of the Board of Directors for two of those companies: Onco Health and 3DR Labs. Prior to joining Arsenal Capital in 2023, he served as the Chief Information and Chief Product Officer for five companies, including three public (Healthways, Vanguard Health, and Kindred Health), and two private equity backed companies (myNEXUS and Compassus) over the course of more than 20 years.